Drug archive
Capecitabine (Systemic)
Archived drug information. This USP DI monograph is kept for reference and dates from the mid-2000s. Doses, warnings, interactions and brand names may have changed, and some products are no longer sold. Always follow your prescriber, your pharmacist and the current label, for example on DailyMed.
Category
- Antineoplastic
Description
Capecitabine (ka-pe-SITE-a-been) belongs to the group of medicines called antimetabolites. It is used to treat breast cancer and colorectal cancer.
Capecitabine interferes with the growth of cancer cells, which are eventually destroyed. Since the growth of normal cells may also be affected by the medicine, other effects will also occur. Some of these may be serious and must be reported to your doctor. Other effects may not be serious but may cause concern.
This medicine is available only with your doctor's prescription, in the following dosage form:
- Tablets (U.S. and Canada)
Brand Names
Some commonly used brand names are:
In the U.S. -
- Xeloda
In Canada -
- Xeloda